Remimazolam tosilate in upper gastrointestinal endoscopy: A multicenter, randomized, non‐inferiority, phase III trial

2020283 citationsJournal Article

Authors

Shaohui Chen · Chinese Academy of Medical Sciences & Peking Union Medical College

Tangmi Yuan · Chinese Academy of Medical Sciences & Peking Union Medical College

Jiao Zhang · Chinese Academy of Medical Sciences & Peking Union Medical College

Hua Bai · Chinese Academy of Medical Sciences & Peking Union Medical College

Ming Tian · Capital Medical University

Chuxiong Pan · Beijing Tongren Hospital

Abstract

This trial established non-inferior sedation success rate of RT compared with propofol. RT allows faster recovery from sedation compared with propofol. The safety profile is favorable and appears to be superior to propofol, indicating that it was feasible and well tolerated for patients.

Topics & Keywords

Anesthesia and Sedative Agents Gastroesophageal reflux and treatments Nausea and vomiting management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Gastroenterology and Hepatology

Volume 36, Issue 2, pp. 474-481

DOI: 10.1111/jgh.15188

Field-Weighted Citation Impact: 29.58